Complete report $32,500. DataPack (test volumes, sales forecasts, supplier shares) $21,100.
This new report from Venture Planning Group contains 1,200 pages, 450 tables and provides forecasts for 40 tumor markers by country and market segment, as well as sales and market shares for reagent and instrument suppliers.
The report is available by region, country, section, market segment and individual test:
Countries: France, Germany, Italy, Japan, Spain, UK, USA
Sections: Assays, Competitors, Instrumentation, Technologies
Market Segments: Hospitals (France, Germany, Italy, Japan, Spain, UK, USA), Personalized Testing
Tests: AFP, Beta-2 Microglobulin, CA Tumor Markers, CEA, Cell Surface Markers, Occult Blood, PAP, Pap Smear/HPV, PSA